Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.
Identifieur interne : 003783 ( PubMed/Checkpoint ); précédent : 003782; suivant : 003784Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.
Auteurs : Filippo Bellati [Italie] ; Roberto Angioli ; Natalina Manci ; Marzio Angelo Zullo ; Ludovico Muzii ; Francesco Plotti ; Stefano Basile ; Pierluigi Benedetti PaniciSource :
- Gynecologic oncology [ 0090-8258 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antinéoplasiques (effets indésirables), Antinéoplasiques (usage thérapeutique), Association thérapeutique, Carcinome épidermoïde (), Carcinome épidermoïde (anatomopathologie), Carcinome épidermoïde (traitement médicamenteux), Cisplatine (effets indésirables), Cisplatine (usage thérapeutique), Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Noeuds lymphatiques (), Noeuds lymphatiques (anatomopathologie), Récidive tumorale locale, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Tumeurs de la vulve (), Tumeurs de la vulve (anatomopathologie), Tumeurs de la vulve (traitement médicamenteux).
- MESH :
- anatomopathologie : Carcinome épidermoïde, Noeuds lymphatiques, Tumeurs de la vulve.
- effets indésirables : Antinéoplasiques, Cisplatine.
- traitement médicamenteux : Carcinome épidermoïde, Tumeurs de la vulve.
- usage thérapeutique : Antinéoplasiques, Cisplatine.
- Adulte d'âge moyen, Association thérapeutique, Carcinome épidermoïde, Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Noeuds lymphatiques, Récidive tumorale locale, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Tumeurs de la vulve.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Carcinoma, Squamous Cell (drug therapy), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (surgery), Cisplatin (adverse effects), Cisplatin (therapeutic use), Combined Modality Therapy, Disease-Free Survival, Female, Humans, Lymph Node Excision, Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphatic Metastasis, Middle Aged, Neoplasm Recurrence, Local, Vulvar Neoplasms (drug therapy), Vulvar Neoplasms (pathology), Vulvar Neoplasms (surgery).
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Cisplatin.
- chemical , therapeutic use : Antineoplastic Agents, Cisplatin.
- drug therapy : Carcinoma, Squamous Cell, Vulvar Neoplasms.
- pathology : Carcinoma, Squamous Cell, Lymph Nodes, Vulvar Neoplasms.
- surgery : Carcinoma, Squamous Cell, Lymph Nodes, Vulvar Neoplasms.
- Aged, Aged, 80 and over, Combined Modality Therapy, Disease-Free Survival, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Middle Aged, Neoplasm Recurrence, Local.
Abstract
The aim of this study was to evaluate acute and long-term morbidity, recurrence rate, and overall survival in patients with multiple groin lymph node metastases treated with postoperative chemotherapy.
DOI: 10.1016/j.ygyno.2004.09.016
PubMed: 15589606
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15589606Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.</title><author><name sortKey="Bellati, Filippo" sort="Bellati, Filippo" uniqKey="Bellati F" first="Filippo" last="Bellati">Filippo Bellati</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Via Longoni, 83-00155 Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Via Longoni, 83-00155 Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Angioli, Roberto" sort="Angioli, Roberto" uniqKey="Angioli R" first="Roberto" last="Angioli">Roberto Angioli</name></author><author><name sortKey="Manci, Natalina" sort="Manci, Natalina" uniqKey="Manci N" first="Natalina" last="Manci">Natalina Manci</name></author><author><name sortKey="Angelo Zullo, Marzio" sort="Angelo Zullo, Marzio" uniqKey="Angelo Zullo M" first="Marzio" last="Angelo Zullo">Marzio Angelo Zullo</name></author><author><name sortKey="Muzii, Ludovico" sort="Muzii, Ludovico" uniqKey="Muzii L" first="Ludovico" last="Muzii">Ludovico Muzii</name></author><author><name sortKey="Plotti, Francesco" sort="Plotti, Francesco" uniqKey="Plotti F" first="Francesco" last="Plotti">Francesco Plotti</name></author><author><name sortKey="Basile, Stefano" sort="Basile, Stefano" uniqKey="Basile S" first="Stefano" last="Basile">Stefano Basile</name></author><author><name sortKey="Panici, Pierluigi Benedetti" sort="Panici, Pierluigi Benedetti" uniqKey="Panici P" first="Pierluigi Benedetti" last="Panici">Pierluigi Benedetti Panici</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15589606</idno><idno type="pmid">15589606</idno><idno type="doi">10.1016/j.ygyno.2004.09.016</idno><idno type="wicri:Area/PubMed/Corpus">003E36</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E36</idno><idno type="wicri:Area/PubMed/Curation">003E36</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003E36</idno><idno type="wicri:Area/PubMed/Checkpoint">003E36</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003E36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.</title><author><name sortKey="Bellati, Filippo" sort="Bellati, Filippo" uniqKey="Bellati F" first="Filippo" last="Bellati">Filippo Bellati</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Via Longoni, 83-00155 Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Via Longoni, 83-00155 Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Angioli, Roberto" sort="Angioli, Roberto" uniqKey="Angioli R" first="Roberto" last="Angioli">Roberto Angioli</name></author><author><name sortKey="Manci, Natalina" sort="Manci, Natalina" uniqKey="Manci N" first="Natalina" last="Manci">Natalina Manci</name></author><author><name sortKey="Angelo Zullo, Marzio" sort="Angelo Zullo, Marzio" uniqKey="Angelo Zullo M" first="Marzio" last="Angelo Zullo">Marzio Angelo Zullo</name></author><author><name sortKey="Muzii, Ludovico" sort="Muzii, Ludovico" uniqKey="Muzii L" first="Ludovico" last="Muzii">Ludovico Muzii</name></author><author><name sortKey="Plotti, Francesco" sort="Plotti, Francesco" uniqKey="Plotti F" first="Francesco" last="Plotti">Francesco Plotti</name></author><author><name sortKey="Basile, Stefano" sort="Basile, Stefano" uniqKey="Basile S" first="Stefano" last="Basile">Stefano Basile</name></author><author><name sortKey="Panici, Pierluigi Benedetti" sort="Panici, Pierluigi Benedetti" uniqKey="Panici P" first="Pierluigi Benedetti" last="Panici">Pierluigi Benedetti Panici</name></author></analytic><series><title level="j">Gynecologic oncology</title><idno type="ISSN">0090-8258</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Carcinoma, Squamous Cell (drug therapy)</term><term>Carcinoma, Squamous Cell (pathology)</term><term>Carcinoma, Squamous Cell (surgery)</term><term>Cisplatin (adverse effects)</term><term>Cisplatin (therapeutic use)</term><term>Combined Modality Therapy</term><term>Disease-Free Survival</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymph Nodes (pathology)</term><term>Lymph Nodes (surgery)</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Vulvar Neoplasms (drug therapy)</term><term>Vulvar Neoplasms (pathology)</term><term>Vulvar Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antinéoplasiques (effets indésirables)</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Association thérapeutique</term><term>Carcinome épidermoïde ()</term><term>Carcinome épidermoïde (anatomopathologie)</term><term>Carcinome épidermoïde (traitement médicamenteux)</term><term>Cisplatine (effets indésirables)</term><term>Cisplatine (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques ()</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Tumeurs de la vulve ()</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Tumeurs de la vulve (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term><term>Cisplatin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term><term>Cisplatin</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome épidermoïde</term><term>Noeuds lymphatiques</term><term>Tumeurs de la vulve</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Cisplatine</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Lymph Nodes</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Lymph Nodes</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinome épidermoïde</term><term>Tumeurs de la vulve</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term><term>Cisplatine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Combined Modality Therapy</term><term>Disease-Free Survival</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Carcinome épidermoïde</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Tumeurs de la vulve</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to evaluate acute and long-term morbidity, recurrence rate, and overall survival in patients with multiple groin lymph node metastases treated with postoperative chemotherapy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15589606</PMID><DateCreated><Year>2004</Year><Month>12</Month><Day>15</Day></DateCreated><DateCompleted><Year>2005</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0090-8258</ISSN><JournalIssue CitedMedium="Print"><Volume>96</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Gynecologic oncology</Title><ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.</ArticleTitle><Pagination><MedlinePgn>227-31</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to evaluate acute and long-term morbidity, recurrence rate, and overall survival in patients with multiple groin lymph node metastases treated with postoperative chemotherapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients affected by FIGO stages III, IVA, and IVB (pelvic lymph nodes only) submitted to surgery were then treated with four cycles of cisplatin 100 mg/m(2) given 21 days apart. Toxicity, overall, and disease-free survival were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen patients were evaluated. Median patients age was 58 (range 48-82). Median performance status was 0 (0-2). All patients completed the treatment. No treatment-related deaths occurred. Only two patients suffered from grade 4 neutropenia during chemotherapy. Three patients suffered from long-term severe lymphedema. Four patients suffered a disease recurrence. Three of these patients were subjected to surgery with no severe postoperative complications. Two of the latter patients are still alive. At a median follow-up of 57.5 months (range 23-79 months) actuarial 3-year overall survival and progression-free survival are 86% and 71%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients affected by vulvar cancer with multiple lymph node metastases, radical surgery followed by chemotherapy is a feasible strategy, with an acceptable short- and long-term complication rate. Results in terms of overall survival and disease-free survival are promising. Furthermore, due to absence of local long-term tissue toxicity, this strategy allows physicians to surgically treat regional lymph node recurrence safely.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellati</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Via Longoni, 83-00155 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angioli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Manci</LastName><ForeName>Natalina</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Angelo Zullo</LastName><ForeName>Marzio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Muzii</LastName><ForeName>Ludovico</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Plotti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Basile</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Panici</LastName><ForeName>Pierluigi Benedetti</ForeName><Initials>PB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gynecol Oncol</MedlineTA><NlmUniqueID>0365304</NlmUniqueID><ISSNLinking>0090-8258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014846" MajorTopicYN="N">Vulvar Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15589606</ArticleId><ArticleId IdType="pii">S0090-8258(04)00738-3</ArticleId><ArticleId IdType="doi">10.1016/j.ygyno.2004.09.016</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><noCountry><name sortKey="Angelo Zullo, Marzio" sort="Angelo Zullo, Marzio" uniqKey="Angelo Zullo M" first="Marzio" last="Angelo Zullo">Marzio Angelo Zullo</name><name sortKey="Angioli, Roberto" sort="Angioli, Roberto" uniqKey="Angioli R" first="Roberto" last="Angioli">Roberto Angioli</name><name sortKey="Basile, Stefano" sort="Basile, Stefano" uniqKey="Basile S" first="Stefano" last="Basile">Stefano Basile</name><name sortKey="Manci, Natalina" sort="Manci, Natalina" uniqKey="Manci N" first="Natalina" last="Manci">Natalina Manci</name><name sortKey="Muzii, Ludovico" sort="Muzii, Ludovico" uniqKey="Muzii L" first="Ludovico" last="Muzii">Ludovico Muzii</name><name sortKey="Panici, Pierluigi Benedetti" sort="Panici, Pierluigi Benedetti" uniqKey="Panici P" first="Pierluigi Benedetti" last="Panici">Pierluigi Benedetti Panici</name><name sortKey="Plotti, Francesco" sort="Plotti, Francesco" uniqKey="Plotti F" first="Francesco" last="Plotti">Francesco Plotti</name></noCountry><country name="Italie"><region name="Latium"><name sortKey="Bellati, Filippo" sort="Bellati, Filippo" uniqKey="Bellati F" first="Filippo" last="Bellati">Filippo Bellati</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003783 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003783 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15589606
|texte= Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15589606" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |